Pulmonary alveolar proteinosis secondary to Pneumocystis jiroveci infection in an infant with common variable...

Area of Science:

• Pediatrics
• Immunology
• Pulmonology

Background:

• Common variable immunodeficiency (CVID) is a primary immunodeficiency characterized by impaired antibody production.
• Pneumocystis pneumonia (PCP) is an opportunistic infection that can occur in immunocompromised individuals.
• Pulmonary alveolar proteinosis (PAP) is a rare lung disease characterized by the accumulation of surfactant in the alveoli.

Observation:

• An infant diagnosed with CVID presented with severe Pneumocystis pneumonia.
• The infant subsequently developed secondary pulmonary alveolar proteinosis (PAP).
• This represents the youngest reported case of PAP secondary to Pneumocystis infection in an immunocompromised infant.

Findings:

• The infant's condition was effectively managed through a multi-modal approach.
• Treatment included antimicrobial agents, frequent lung lavage (lung toilet), and optimized mechanical ventilation.
• Supportive care played a crucial role in the infant's recovery.

Implications:

• This case highlights the potential for rare complications like PAP in infants with CVID and PCP.
• It underscores the importance of prompt diagnosis and aggressive management of opportunistic infections in immunocompromised infants.
• The successful outcome suggests that a combination of antimicrobial therapy, respiratory support, and lung hygiene can be effective in managing secondary PAP in this population.